Financials
Financial year 2025
NOVOLAB from Geraardsbergen, company number BE0426668554, closed financial year 2025 with a result of € 180,635 after tax. For that financial year NOVOLAB recorded revenue of € 6.5 million and equity of € 2.1 million. Compared with financial year 2024, the result moved from € 424,944 to € 180,635. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 23, 2025.
€ 2.1 million
▲ 10% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 180,635
▼ 57% vs 2024
Profit after tax over the fiscal year.
€ 1.2 million
▼ 25% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 2 million.
People and assets in 2025
13.9
▲ 1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 962,000
▲ 17% vs 2024
€ 69,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 56,780
▼ 70% vs 2024
Loans from banks and other lenders, long and short.
€ 433,783
▼ 2% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 204,777
▲ 11% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | - | - | - | € 6,515,756 | |
| Gross margin | € 1,812,475 | € 1,869,569 | € 1,403,150 | € 1,230,832 | ▼ 12% |
| Profit after taxes | € 703,504 | € 709,406 | € 424,944 | € 180,635 | ▼ 57% |
| Equity | € 1,796,887 | € 2,306,293 | € 1,881,237 | € 2,061,872 | ▲ 10% |
| Total debts | € 2,318,065 | € 1,729,329 | € 1,926,244 | € 1,305,276 | ▼ 32% |
| Cash | € 1,617,060 | € 1,836,382 | € 1,627,383 | € 1,222,015 | ▼ 25% |
| Land & buildings | € 62,623 | € 101,154 | € 128,074 | € 151,999 | ▲ 19% |
| Retained profit | € 1,727,600 | € 2,237,006 | € 1,811,950 | € 1,992,585 | ▲ 10% |
| Dividend | € 200,000 | € 200,000 | € 850,000 | € 0 | ▼ 100% |
| Bank debt | € 1,084,818 | € 335,957 | € 188,907 | € 56,780 | ▼ 70% |
| Balance sheet total | € 4,165,237 | € 4,060,557 | € 3,809,016 | € 3,368,683 | ▼ 12% |
| Employees (FTE) | 12.6 | 12.7 | 12.9 | 13.9 | ▲ 1 |
Key figures of NOVOLAB, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to NOVOLAB?
What happened at NOVOLAB in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 180,635 (▼ 57% vs 2024). Source: NBB ↗
- New establishment in Geraardsbergen. KBO
- Start of the company according to the CBE. KBO
In short
From € 703,504 profit in 2022 to € 180,635 profit in 2025.
Paid € 715,946 in corporate taxes since 2022.
Best year ever: 2023, with € 709,406 profit.
On average € 88,500 of value added per employee in 2025.
Establishments
Establishment units
Physical locations of this company
Diebeke(Sch) 7
9500 Geraardsbergen
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0426.668.554
- VAT number
- BE 0426.668.554
- Registered office
- Diebeke(Sch) 7, 9500 Geraardsbergen
- Names & denominations
- NOVOLAB
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 10 December 1984
- Peppol
- Active · Active since 15 Dec 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Overige niet-gespecialiseerde detailhandel
Detailhandel via postorderbedrijven of via internet